EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study

Dag Holmberg iD, Joonas H Kauppila, Johannes Asplund, Wilhelm Leijonmarck, Fredrik Mattsson, Jesper Lagergren

Gastric Cancer · 2024

DOI: 10.1007/s10120-024-01487-5 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Gastric Cancer, 2024. Verfasst von Dag Holmberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Retzius Street 13A, 4th Floor, 171 77, Stockh…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stomach Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Cancerfonden, Cancerföreningen i Stockholm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies have suggested that medication with statins improves survival in patients with gastric cancer, but methodological issues have limited the interpretability and prohibited conclusive results. We aimed to provide valid evidence as to whether statin use improves survival of gastric adenocarcinoma.

Methods

This nationwide and population-based cohort study included virtually all patients who underwent curatively intended surgery (gastrectomy) for gastric adenocarcinoma in Sweden between 2006 and 2015 with follow-up throughout 2019 for disease-specific mortality and 2020 for all-cause mortality. Data came from medical records and national healthcare registries. The exposure was statin use during the year prior to gastrectomy which was compared to no such use during the same period. The outcomes were 5-year disease-specific mortality (main) and 5-year all-cause mortality (secondary). Multivariable Cox regression provided hazard ratios (HR) with 95% confidence intervals (CI), adjusted for age, sex, education, calendar year, comorbidity, low-dose aspirin use, tumour sublocation, pathological tumour stage, neoadjuvant chemotherapy, annual surgeon volume, and surgical radicality.

Results

Among 1515 participating patients, the mean age was 69 years and 58.4% were men. Statin use, identified in 399 (26.3%) patients, was not associated with any statistically significantly decreased 5-year disease-specific mortality ( HR 0.99, 95% CI 0.82–1.21) or 5-year all-cause mortality (HR 0.94, 95% CI 0.79–1.12). No risk reductions were found across subgroups of age, sex, aspirin user status, or tumour stage, or in patients with long-term preoperative of postoperative use of statins, all with point estimates close to 1.

Conclusions

Perioperative use of statins does not seem to improve the 5-year survival in patients who undergo gastrectomy with curative intent for gastric adenocarcinoma in Sweden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsStomach NeoplasmsAdenocarcinomaMaleHumansAgedFemalePrognosisCohort StudiesSwedenGastrectomyAspirinRetrospective Studies

Stichwörter der Autor:innen

ChemopreventionGastrectomyGastric neoplasmHyperlipidaemia

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsAspirin

Autor:innen und Institutionen

  • Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Retzius Street 13A, 4th Floor, 171 77, Stockholm, Sweden. dag.holmberg@ki.se.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Retzius Street 13A, 4th Floor, 171 77, Stockholm, Sweden.
  • Department of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • School of Cancer and Pharmacological Sciences, King's College London, London, UK.

ORCID-Profile: Dag Holmberg

Förderung

  • Vetenskapsrådet
  • Cancerfonden
  • Cancerföreningen i Stockholm
  • Karolinska Institute

Zitieren

APA

Holmberg, D., Kauppila, J. H., Asplund, J., Leijonmarck, W., Mattsson, F., & Lagergren, J. (2024). Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study. Gastric Cancer. https://doi.org/10.1007/s10120-024-01487-5

Vancouver

Holmberg D, Kauppila JH, Asplund J, Leijonmarck W, Mattsson F, Lagergren J. Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study. Gastric Cancer. 2024. doi:10.1007/s10120-024-01487-5

BibTeX
@article{Holmberg2024,
  author = {Holmberg, Dag and Kauppila, Joonas H and Asplund, Johannes and Leijonmarck, Wilhelm and Mattsson, Fredrik and Lagergren, Jesper},
  title = {Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study},
  journal = {Gastric Cancer},
  year = {2024},
  doi = {10.1007/s10120-024-01487-5}
}
Kostenlos starten →